Forte Biosciences (FBRX) Enterprise Value (2016 - 2020)
Forte Biosciences (FBRX) has disclosed Enterprise Value for 5 consecutive years, with -$20.2 million as the latest value for Q3 2020.
- Quarterly Enterprise Value rose 21.13% to -$20.2 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was -$20.2 million through Sep 2020, up 21.13% year-over-year, with the annual reading at -$6.9 million for FY2019, 83.0% up from the prior year.
- Enterprise Value for Q3 2020 was -$20.2 million at Forte Biosciences, up from -$27.7 million in the prior quarter.
- The five-year high for Enterprise Value was -$4.1 million in Q3 2016, with the low at -$76.1 million in Q2 2017.
- Average Enterprise Value over 5 years is -$24.5 million, with a median of -$20.2 million recorded in 2020.
- The sharpest move saw Enterprise Value tumbled 1730.77% in 2017, then soared 83.0% in 2019.
- Over 5 years, Enterprise Value stood at -$5.5 million in 2016, then plummeted by 552.14% to -$35.9 million in 2017, then decreased by 13.58% to -$40.8 million in 2018, then skyrocketed by 83.0% to -$6.9 million in 2019, then plummeted by 190.75% to -$20.2 million in 2020.
- According to Business Quant data, Enterprise Value over the past three periods came in at -$20.2 million, -$27.7 million, and -$14.2 million for Q3 2020, Q2 2020, and Q1 2020 respectively.